Compositions and Methods for Reprogramming Diseased Musculoskeletal Cells

Sun, 12 Apr 2026 03:20:13 +0000
Intellectual Property

USPTO published patent application US20260097131A1 titled 'Compositions and Methods for Reprogramming Diseased Musculoskeletal Cells.' The application (filed December 11, 2025) discloses compositions and methods for reprogramming diseased musculoskeletal cells both in vitro and in vivo using non-viral delivery of polynucleotides encoding transcription factors. The patent application is now publicly available.